Beijing Wandong Medical Technology Co., Ltd. (600055.SS)
CNY 16.19
(-0.37%)
CNY 16.19
(-0.37%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.22 Billion | 1.12 Billion | 1.15 Billion | 1.13 Billion | 982.37 Million | 954.52 Million |
| Cost of Revenue | 730.28 Million | 626.61 Million | 626.4 Million | 561.74 Million | 521.89 Million | 538.32 Million |
| Gross Profit | 494.52 Million | 494.59 Million | 529.77 Million | 570.15 Million | 460.47 Million | 416.2 Million |
| Operating Expenses | 307.63 Million | 360.41 Million | 337.78 Million | 270.97 Million | 258.34 Million | 243.95 Million |
| Selling, General and Administrative Expenses | 309.26 Million | 197.41 Million | 211.66 Million | 162.42 Million | 170.51 Million | 173.26 Million |
| Research and Development Expenses | 164.91 Million | 137.75 Million | 111.47 Million | 86.41 Million | 70.18 Million | 61.89 Million |
| Other Expenses | -166.54 Million | 25.24 Million | 14.63 Million | 22.14 Million | 17.63 Million | -4.03 Million |
| Cost and Expenses | 1.02 Billion | 987.02 Million | 964.18 Million | 832.72 Million | 780.23 Million | 782.28 Million |
| Operating Income | 213.32 Million | 192.54 Million | 208.74 Million | 263.95 Million | 188.85 Million | 177.15 Million |
| Interest Expense | 1.69 Million | 1.46 Million | 1.5 Million | 2.08 Million | 772.34 Thousand | 869 Thousand |
| Income Tax Expense | 22.52 Million | 20.39 Million | 26.95 Million | 45.48 Million | 26.13 Million | 23.9 Million |
| Earnings before Tax | 213.33 Million | 192.43 Million | 207.22 Million | 263.76 Million | 191.15 Million | 173.12 Million |
| Net Income | 188.53 Million | 175.36 Million | 183.19 Million | 220.66 Million | 168.88 Million | 153.33 Million |
| Earnings Per Share Basic | 0.27 | 0.27 | 0.34 | 0.41 | 0.32 | 0.28 |
| Earnings Per Share Diluted | 0.27 | 0.27 | 0.34 | 0.41 | 0.32 | 0.28 |
| Weighted Average Shares Outstanding | 698.28 Million | 649.51 Million | 535.87 Million | 535.87 Million | 535.87 Million | 540.81 Million |
| Weighted Average Shares Outstanding (Diluted) | 698.28 Million | 649.51 Million | 535.87 Million | 535.87 Million | 535.87 Million | 547.61 Million |
| Gross Margin | 0.40 | 0.44 | 0.46 | 0.50 | 0.47 | 0.44 |
| EBIT Margin | 0.21 | 0.24 | 0.23 | 0.31 | 0.29 | 0.25 |
| Profit Margin | 0.15 | 0.16 | 0.16 | 0.19 | 0.17 | 0.16 |
| EBITDA | 257.43 Million | 228.6 Million | 249.03 Million | 304.37 Million | 230.97 Million | 211.96 Million |
| Earnings Before Tax Margin | 0.17 | 0.17 | 0.18 | 0.23 | 0.19 | 0.19 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 392.99 Million | 386.14 Million | 308.49 Million | 306.37 Million | 1.22 Billion | 331.45 Million |
| Cost of Revenue | 250.78 Million | 235.3 Million | 192.94 Million | 176.53 Million | 730.28 Million | 188.49 Million |
| Gross Profit | 142.21 Million | 150.83 Million | 115.55 Million | 129.84 Million | 494.52 Million | 142.96 Million |
| Operating Expenses | 117.28 Million | 106.98 Million | 96.78 Million | 137.54 Million | 453.1 Million | 107.88 Million |
| Selling, General and Administrative Expenses | 173.04 Million | 67.01 Million | 67.58 Million | 91.61 Million | - | 101.28 Million |
| Research and Development Expenses | 36.52 Million | 39.96 Million | 35.18 Million | 43.81 Million | - | 45.2 Million |
| Other Expenses | -92.29 Million | -4870.00 | -21.4 Thousand | -2.11 Million | -2.1 Million | -493.14 Thousand |
| Cost and Expenses | 368.06 Million | 342.29 Million | 289.72 Million | 314.07 Million | 1.18 Billion | 296.38 Million |
| Operating Income | 37.31 Million | 43.85 Million | 37.56 Million | -7.7 Million | 41.42 Million | 52.27 Million |
| Interest Expense | 125.8 Thousand | 282.23 Thousand | - | 686.04 Thousand | 1.25 Million | 175.38 Thousand |
| Income Tax Expense | 5.6 Million | 13.53 Million | 3.36 Million | -1.42 Million | 22.52 Million | 7.59 Million |
| Earnings before Tax | 36.73 Million | 65 Million | 37.53 Million | 68.69 Million | 215.38 Million | 51.78 Million |
| Net Income | 30.99 Million | 51.48 Million | 33.25 Million | 68.35 Million | 188.53 Million | 44.14 Million |
| Earnings Per Share Basic | 0.04 | 0.07 | 0.05 | 0.10 | - | 0.06 |
| Earnings Per Share Diluted | 0.04 | 0.07 | 0.05 | 0.10 | - | 0.06 |
| Weighted Average Shares Outstanding | 703.06 Million | 703.06 Million | 707.6 Million | 703.06 Million | 703.06 Million | 703.06 Million |
| Weighted Average Shares Outstanding (Diluted) | 703.06 Million | 703.06 Million | 707.6 Million | 703.06 Million | 703.06 Million | 703.06 Million |
| Gross Margin | 0.36 | 0.39 | 0.37 | 0.42 | 0.40 | 0.43 |
| EBIT Margin | 0.09 | 0.14 | 0.06 | 0.01 | - | 0.16 |
| Profit Margin | 0.08 | 0.13 | 0.11 | 0.22 | 0.15 | 0.13 |
| EBITDA | 36.86 Million | 54.28 Million | 18.76 Million | 2.12 Million | - | 52.01 Million |
| Earnings Before Tax Margin | 0.09 | 0.11 | 0.12 | -0.03 | 0.03 | 0.16 |
AI
0R43
688550
0058
ENTRA
ABANF